<DOC>
	<DOCNO>NCT02063399</DOCNO>
	<brief_summary>The purpose study determine screen nasopharyngeal carcinoma use plasma Epstein-Barr virus DNA analysis would result down-staging NPC case asymptomatic individual .</brief_summary>
	<brief_title>Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis</brief_title>
	<detailed_description>Epstein-Barr virus ( EBV ) infection important etiological factor nasopharyngeal carcinoma ( NPC ) . In pilot study , show analysis Epstein-Barr virus ( EBV ) DNA blood detect early asymptomatic NPC . However , unlcear NPC screen improve prognosis screen NPC subject . 20,000 male subject age 40 60 recruit incidence NPC high target group . Twenty millilitre venous blood collect subject enrolment plasma EBV DNA analysis . Subjects initial positive result plasma EBV DNA another test within 4 week . Subjects persistently positive result two plasma EBV DNA analyse investigate use nasal endoscopic examination . A third blood sample collect day endoscopy . For subject persistently positive plasma EBV DNA result three occasion negative endoscopy result investigate MRI . After initial screening , participant phone interview yearly update cancer status .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>age 40 60 year ethnic Chinese male history nasopharyngeal carcinoma currently malignant disease active autoimmune disease HIV infection systemic steroid treatment immunosuppressant treatment</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>NPC</keyword>
	<keyword>Cancer screen</keyword>
	<keyword>Plasma EBV DNA</keyword>
</DOC>